• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 10/30/14

    • 30-Day SEC Yield1

      -0.13%
    • Total Net Assets

      $636.5M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/19/2014
  • Portfolio Composition (%)
    as of 10/30/14

    • % of Net Assets
    • Stocks

      99.90
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.10
  • Download All HoldingsAll Holdings (%)as of 10/30/14

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    856,872
    97,871,92015.38
    Amgen Inc
    AMGN US
    474,899
    76,734,18412.06
    Celgene Corp
    CELG US
    593,147
    63,431,1409.97
    Biogen Idec Inc
    BIIB US
    149,602
    48,022,2407.55
    Alexion Pharmaceuticals Inc
    ALXN US
    177,298
    34,206,1045.37
    Vertex Pharmaceuticals Inc
    VRTX US
    278,998
    30,926,9284.86
    Regeneron Pharmaceuticals Inc
    REGN US
    74,597
    29,301,7024.60
    Illumina Inc
    ILMN US
    148,376
    28,698,8864.51
    Biomarin Pharmaceutical Inc
    BMRN US
    293,548
    24,176,6143.80
    Incyte Corp Ltd
    INCY US
    368,349
    23,640,6383.71
    Pharmacyclics Inc
    PCYC US
    170,408
    22,936,0643.60
    Medivation Inc
    MDVN US
    203,310
    20,888,0703.28
    Qiagen Nv
    QGEN US
    802,239
    19,005,0422.99
    United Therapeutics Corp
    UTHR US
    116,082
    15,140,5752.38
    Puma Biotechnology Inc
    PBYI US
    54,320
    13,440,3982.11
    Cubist Pharmaceuticals Inc
    CBST US
    177,266
    12,851,7852.02
    Alkermes Plc
    ALKS US
    223,827
    11,480,0871.80
    Isis Pharmaceuticals Inc
    ISIS US
    234,920
    10,778,1301.69
    Intercept Pharmaceuticals Inc
    ICPT US
    39,892
    10,241,4731.61
    Covance Inc
    CVD US
    127,986
    10,153,1291.60
    Charles River Laboratories Internationa
    CRL US
    128,957
    8,099,7891.27
    Cepheid Inc
    CPHD US
    140,091
    7,476,6571.17
    Nps Pharmaceuticals Inc
    NPSP US
    249,427
    7,098,6931.12
    Myriad Genetics Inc
    MYGN US
    134,077
    5,094,9260.80
    Seattle Genetics Inc
    SGEN US
    118,422
    4,174,3760.66
    Other/Cash
    606,0120.10
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.